Nebenwirkungen · Pioglitazone Actavis
Pioglitazone Actavis 15 mg tablets Pioglitazone Actavis 30 mg tablets Pioglitazone Actavis 45 mg tablets · Abschnitt 4.8 · PDF-Seite 8–9
HOS-214493 · Präparat HOS-155342
8 Frequency of adverse reactions of pioglitazone by treatment regimen Combination Adverse with reaction Mono- with with sulpho- metformin therapy with insulin metformin nylurea and sulpho- nylurea Skin and subcutaneous tissue disorders sweating uncommon Musculoskeletal and connective tissue disorders fracture bone4 common common common common common arthralgia common common common back pain common Renal and urinary disorders haematuria common glycosuria uncommon proteinuria uncommon Reproductive system and breast disorders erectile common dysfunction General disorders and administration site conditions oedema5 very common fatigue uncommon Investigations weight increased6 common common common common common blood creatine common phospho-kinase increased increased lactic uncommon dehydro-genase Alanine not known not known not known not known not known aminotransferase increased7
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2023-06-01T02:00:00Z · SHA-256 ad23e703c99e588d5e3753a426a2d517a2d2fd35bbce3778e82f258ef487d9a7 · Passage c37afdd47beaad7ce5de5f679e6bf009cf8538c983af9dc718e07d2d02dc32d3 · Zeichen 3799–5833 im Abschnitt